Zephyrnet Logo

Tag: clinical trials

Can Magic Mushrooms Make You Paranoid Like Weed Sometimes Does? – No, New Study on Psilocybin Says No Risk of Paranoia

As more and more studies explore the potential therapeutic benefits of psilocybin, the main hallucinogenic ingredient in magic mushrooms, encouraging results are being found...

Top News

It’s Time to Ditch the Idea of Edtech Disruption. But What Comes Next? – EdSurge News

COVID-19 was edtech’s big moment, and while digital tools kept learning going for many families and schools, they also faltered. A great deal of...

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

TOKYO, Apr 10, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment...

Journey Through “February” on SpicyIP (2005 – Present)

<img decoding="async" width="851" height="1024" data-attachment-id="47371" data-permalink="https://spicyip.com/2024/04/journey-through-february-on-spicyip-2005-present.html/spicyip-feb" data-orig-file="https://spicyip.com/wp-content/uploads/2024/04/SpicyIP-Feb.jpeg" data-orig-size="1000,1203" data-comments-opened="1" data-image-meta="{"aperture":"0","credit":"rawpixel.com / Rijksmuseum (Source)","camera":"","caption":"Kalenderblad voor februari van de kalender 'Bloem en blad' (c. 1900 -...

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ | BioSpace

Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) Over 28,000 cases of multiple sclerosis (MS)...

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S....

TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the...

NMPA Usability Engineering Guideline Issued for Medical Devices

NMPA published the “Medical Devices Usability Engineering Guideline” on March 19, 2024. NMPA believes that, in improving the usability and the design of devices...

Sequana Medical announces 2023 Full Year Results and 2024 Outlook | BioSpace

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 March 2024, 08:00 a.m. CET alfapump® – PMA1 submitted to US FDA and accepted for substantive review, extensive feedback...

The Commercialization of Asia’s First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough

HONG KONG, Mar 27, 2024 - (ACN Newswire) - In 2023, CanSinoBIO's meningococcal conjugate vaccine achieved revenue approximately RMB561.72 million, representing a year-on-year increase...

How Artificial Intelligence Will First Find Its Way Into Mental Health – DATAVERSITY

Artificial intelligence (AI) startup Woebot Health made the news recently for some of its disastrously flawed artificial bot responses to text messages that were...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?